Updated Q3 2026 by CT Acquisitions.

Dental practice acquisition financing: the 2026 LMM operator’s guide

Dental practice acquisition financing is the layered capital stack a buyer assembles to purchase one dental office, a multi-location group, or an emerging DSO platform, and in 2026 that stack looks nothing like the pre-2022 playbook. Base rates on SBA 7(a) loans were priced at Prime plus 2.25 to 2.75 percent through the first half of 2026, with Prime at 7.50 percent per the Federal Reserve, which puts an SBA-financed single-office deal in the low double digits on a fully-amortizing basis. That interest-rate reality, combined with roughly $1.2 trillion of private-equity dry powder tracked by PitchBook’s Q2 2026 US PE Breakdown and a bifurcated DSO valuation market documented by McKinsey, means the sponsor mix, junior-debt appetite, and equity check size a buyer would target in 2026 have all shifted. This guide is written for lower-middle-market operators, DSO founders in the $1M to $25M EBITDA band, and dentist-buyers using search-fund-style structures, not for pre-seed startup founders or first-time DIY buyers.

What is dental practice acquisition financing?

Dental practice acquisition financing is the debt and equity capital a buyer combines to purchase a dental office, multi-office group, or DSO platform, sized to the target’s EBITDA and cash-flow coverage. For a $600K EBITDA single office at a 5x multiple, the stack would typically be an SBA 7(a) loan up to $5M, a 5 to 10 percent seller note on standby, and 10 percent buyer equity, per SBA SOP 50 10 8.

The phrase covers a wide spectrum in practice. On the small end, a solo dentist-buyer acquiring a $500K EBITDA general practice will assemble an SBA 7(a) loan, a seller note, and a 10 percent equity injection, with the whole capital raise settling under $3M of enterprise value. On the larger end, a private-equity-backed DSO platform buying a 12-location roll-up in the Southeast might layer a $60M unitranche from Golub Capital or Ares Capital Corporation, a $15M second-lien or preferred slug, and $25M of sponsor equity from a growth-equity fund such as InTandem Capital Partners or Latticework Capital, with the entire transaction rolling closed in 90 days from a signed LOI. The plumbing differs, but the vocabulary and diligence pathway rhyme.

What separates dental from other healthcare service verticals is regulatory tolerance for the DSO structure. Corporate-practice-of-dentistry rules vary by state, with roughly 20 states permitting some form of DSO management-services organization arrangement and others requiring a friendly-professional-corporation shell. The American Dental Association tracks the regulatory landscape state-by-state, and any acquisition financing package assembled without that overlay stress-tested will not survive lender or sponsor legal review.

Who typically uses dental practice acquisition financing?

Three buyer archetypes drive demand for dental practice acquisition financing in 2026: solo dentist-buyers acquiring their first or second office (SBA-heavy), operator-led search funds and independent sponsors rolling up 3 to 8 locations (SBA plus mezzanine or unitranche), and private-equity-backed DSO platforms executing add-on deals inside a larger buy-and-build (institutional debt plus sponsor equity). CT Acquisitions works with all three but focuses primarily on the LMM tier, defined as $1M to $25M EBITDA per GF Data.

The solo dentist-buyer represents the largest volume by transaction count. Live Oak Bank alone originated more than $1.4 billion of dental practice loans in 2024 per its Q4 2024 investor deck, most of which was SBA-eligible single-office acquisitions or associate buy-ins. These buyers care about monthly debt-service coverage above 1.25x and post-debt-service owner comp above the associate-doctor market rate.

The operator-led search fund is the fastest-growing archetype. Programs such as the Stanford GSB Search Fund Study 2024 and its 2026 update document rising interest in healthcare services searches, with dental groups a top-three vertical. These buyers combine SBA where possible with a seller note, private junior debt from firms such as Enhanced Capital or Ironwood Capital, and a small equity check from search-fund investors such as Search Fund Partners, Anacapa Partners, or Pacific Lake Partners.

The institutional platform buyer sits at the top of the market. Sponsors including KKR (Heartland Dental), Ares Management (Aspen Dental), and Linden Capital Partners (Smile Doctors) run add-on programs where each dental office joins an existing platform, and the acquisition financing is drawn from the platform’s revolving credit facility or unitranche upsize rather than a bespoke transaction.

How does dental practice acquisition financing compare to alternatives?

Dental practice acquisition financing sits in a menu that includes seller-only financing (rare above $1M EBITDA), SBA 7(a) for deals under $5M, conventional practice-lender debt (Live Oak, Provide, BofA Practice Solutions), unitranche and second-lien for $10M+ deals, and equity-heavy PE recap or platform sales. The right mix depends on target EBITDA, buyer type, and the seller’s willingness to hold paper. A 2024 Axial LMM report found that healthcare services deals used a median 55 to 65 percent debt weighting.

The core trade-off is dilution versus fixed-cost drag. Debt-heavy structures preserve buyer equity but push a large fixed obligation onto the practice’s cash flows. In a rate environment where Prime is 7.50 percent, a 10-year fully-amortizing $4M SBA 7(a) loan at Prime plus 2.5 percent consumes roughly $54K per month of debt service, which on a $600K EBITDA practice is more than half the annual free cash flow. Equity-heavy structures, by contrast, transfer economic upside to the outside investor, so a founder-dentist selling 60 percent to a growth-equity sponsor gives away a proportional share of the next exit multiple expansion.

The growth equity versus private equity comparison guide and mezzanine debt for acquisitions guide published on CT Acquisitions walk through the numeric consequences at $5M, $15M, and $50M enterprise-value bands. The short version: SBA wins on cost when it fits, unitranche wins on speed and flexibility above $10M, and equity-only structures win when the seller is under-diligenced or wants a full walk-away.

Table 1: Capital-source comparison for dental practice acquisition financing

When does dental practice acquisition financing make sense?

Dental practice acquisition financing makes sense whenever a buyer wants to acquire a going-concern practice with normalized owner-doctor EBITDA above $250K and a defensible payer mix. Below that threshold, a build-your-own de novo often beats an acquisition on unit economics. Above $3M EBITDA, the deal is large enough that sponsor equity or unitranche debt becomes competitive with SBA financing, and the buyer would typically run a two-track process, per PwC health services M&A commentary.

Fit criteria that materially affect financing availability include: hygiene revenue mix above 25 percent of collections (predictable recurring cash flow the lender can underwrite), fee-for-service versus PPO mix above 40 percent (higher net yields, less payer risk), payer concentration under 20 percent from any single insurer, associate-doctor productivity above 60 percent of the departing owner’s collections, and lease-term remaining above 5 years or a clean assignment path.

Bad-fit scenarios where a buyer would typically walk from acquisition financing altogether: a Medicaid-heavy practice in a state where reimbursement is under active reform, a single-provider practice where 80 percent of goodwill walks with the owner, a location with a lease expiring inside 24 months and a landlord unwilling to extend, or an EBITDA base that leans on non-recurring case-fee spikes such as one-time full-arch reconstruction cases.

How much does dental practice acquisition financing cost?

The all-in cost of dental practice acquisition financing runs from 8 to 15 percent blended cost of capital in 2026, depending on the debt mix. A pure SBA 7(a) stack costs roughly 10 percent on the debt piece plus SBA guarantee fee of 0 to 3.75 percent per SBA fee schedule. A unitranche-plus-equity stack blends to 12 to 14 percent. A pure minority recap has zero cash cost but transfers economic ownership.

Direct fees layered on any financing package include: lender origination points (1 to 2 percent on SBA, 2 to 3 percent on unitranche), legal fees ($75K to $250K depending on complexity), quality of earnings ($50K to $150K from CBIZ, Aprio, Withum, or dental-specialist firm PracticeCS), transaction insurance (rep-and-warranty premiums running 3 to 5 percent of coverage limit per Marsh 2025 M&A insurance market report), and advisory fees (retainer plus success fee for buy-side or sell-side representation).

Table 2: 2026 cost, dilution, and timeline breakdown by capital source

Who provides dental practice acquisition financing?

The 2026 provider landscape splits into specialty practice lenders (Live Oak Bank, Provide by Fifth Third, Bank of America Practice Solutions, Huntington, TAB Bank), unitranche and BDC lenders (Ares Capital Corporation, Golub Capital, Owl Rock, Blue Owl), family offices with healthcare focus (Fireside Investments, Riata Capital, Latticework Capital), and DSO platforms deploying add-on capital directly (Heartland Dental backed by KKR, Aspen Dental backed by Ares, Smile Doctors backed by Linden Capital and Thomas H. Lee Partners).

Specialty practice lenders dominate the sub-$10M single and multi-office acquisition segment. Live Oak Bank published $1.4B of dental originations in 2024 per its investor filings, Provide is the merged Fifth Third dental-lending business, BofA Practice Solutions runs one of the largest legacy books, and TAB Bank has grown its niche healthcare book aggressively since 2023.

Unitranche and BDC lenders enter above the $10M debt-size threshold. Ares Capital Corporation, Golub Capital, Owl Rock, and Blue Owl compete on speed and single-tranche flexibility for platform-level DSO leverage. Their pricing reference is SOFR plus 550 to 750 basis points in 2026, per S&P LCD middle-market data.

Table 3: Named 2026 dental acquisition financing sponsors and lenders

In our experience advising LMM operators raising dental practice acquisition financing, the single most common misstep is treating the debt provider selection as commoditized. Two lenders quoting the same headline rate can differ by 200 basis points in true all-in cost once you back out origination fees, prepayment penalties, life-of-loan personal guarantee mechanics, and covenant packages. A CT-run process routinely sources three to five term sheets, and the winning quote is rarely the lowest coupon on the cover page. It is the one whose covenants, guarantee release triggers, and add-on facility mechanics align with the buyer’s actual growth plan for the next 36 months.

How does the dental practice acquisition financing process work?

The dental practice acquisition financing process runs eight to twelve steps depending on capital source. For an SBA-heavy single-office deal the sequence is: buyer prequalification, LOI, appraisal and business valuation, SBA lender package assembly, third-party diligence (QoE, legal, real estate), SBA credit approval, closing docs, funding. For a PE-backed deal add sponsor selection, term sheet, exclusivity, confirmatory diligence, and legal negotiation on definitive documents, typically running 90 to 150 days per Bain & Company Global Private Equity Report.

1. Buyer prequalification and financing capacity. Assemble personal financial statement, tax returns, and DDS credential documentation. Specialty lenders can prequalify within 5 business days.
2. Target sourcing and initial NDA. Direct outreach, broker relationships, or platform introductions such as Dentaltown practice-for-sale boards.
3. Non-binding LOI with financing contingency. Ties up target for 45 to 90 days of exclusivity; specifies purchase price, structure, and closing timeline.
4. Business appraisal and valuation. SBA-mandated when deal exceeds $250K; ordered from an SBA-qualified appraiser.
5. Quality of earnings. Dental-specialist QoE from CBIZ, Aprio, Withum, or PracticeCS. Normalizes owner comp, associate production, and hygiene productivity.
6. Legal, tax, and reg diligence. Corporate-practice-of-dentistry compliance, malpractice claim history, OSHA and HIPAA record review.
7. Real estate diligence. Lease review or acquisition of the underlying building via SBA 504 or conventional CRE loan.
8. Lender or sponsor credit approval. Investment committee review, term sheet issuance.
9. Definitive documents. Asset or stock purchase agreement, seller note, employment agreement for outgoing dentist.
10. Regulatory approvals. State dental board notifications, provider re-credentialing initiated.
11. Closing and funding. Wires cross, keys change hands, employees transfer.
12. Post-close integration. Payer re-contracting, practice-management system conversion, patient continuity communication.

What paperwork and documentation is required?

Dental practice acquisition financing paperwork spans three buckets: buyer-side (personal financials, credit reports, dental license, resume), target-side (3 to 5 years of tax returns, monthly production reports, payer mix analysis, patient count and recall data, lease and employment agreements), and transaction-side (LOI, purchase agreement, seller note, non-compete, employment agreement, financing commitment). Lenders such as Live Oak Bank publish standard checklists on their websites, and a full SBA 7(a) file will typically exceed 500 pages.

Target-side documents that reliably surface issues in diligence include: the payer mix aging report by insurance carrier (reveals concentration risk), production-by-provider report over 24 months (isolates owner-dependence), hygiene department P&L (validates recurring revenue quality), and equipment lease schedule (uncovers hidden capex or balloon obligations).

On the buyer side, SBA 7(a) requires SBA Form 1919, SBA Form 413 personal financial statement, three years of personal tax returns, resume demonstrating dental industry experience, and evidence of the 10 percent equity injection. If a search fund or independent sponsor structure applies, the sponsor’s fund docs and equity commitment letter substitute for the individual buyer’s financials up to the SBA cap.

What are the tax and legal implications of dental practice acquisition financing?

The dominant tax and legal decisions in a dental practice acquisition financing are: asset versus stock deal (asset deals typically preferred by buyers for step-up basis and liability isolation, per IRS Publication 544), goodwill allocation on IRS Form 8594, section 338(h)(10) election eligibility for S-corp targets, and corporate-practice-of-dentistry MSO structure. Bad tax structuring can cost 5 to 15 percent of enterprise value at exit, per KPMG M&A tax commentary.

Asset deals dominate dental transactions below $25M enterprise value because they let the buyer step up basis on tangible equipment and amortize goodwill over 15 years under IRC 197. Sellers taxed on ordinary income for equipment recapture and depreciation clawbacks would typically negotiate for a section 1060 allocation weighted toward goodwill (capital gains treatment).

The corporate-practice-of-dentistry (CPD) legal framework governs whether a non-dentist entity can own the practice or must operate through a friendly PC / management-services organization structure. States including California, New York, Texas, and Illinois enforce strict CPD rules that shape every DSO structure; a buyer or sponsor unfamiliar with the state-specific overlay would spend an extra 30 to 60 days of legal diligence relative to a state-agnostic structure. The American Bar Association Health Law Section maintains reference materials on state-by-state CPD variation.

What are the common deal structures and terms?

Common dental practice acquisition financing structures in 2026 include: 100 percent asset sale with SBA plus seller note (single office under $5M EV), asset sale with earnout tied to associate-doctor retention or payer transitions (multi-location under $25M EV), MSO plus friendly PC structure with rollover equity (DSO platform or add-on), and majority recap with 20 to 40 percent rollover (institutional PE recap). Per SRS Acquiom 2025 SPA Deal Terms Study, healthcare-services deals show above-average use of earnouts and R&W insurance.

Earnout structures commonly used in dental deals: 12 to 24-month earnout tied to same-store revenue or EBITDA achievement (10 to 25 percent of enterprise value), payer-transition earnout tied to successful re-contracting of top three insurance carriers, and associate-doctor retention earnout tied to key producers staying past the transition date. Well-drafted earnouts specify a cap, a floor, an exact accounting protocol, and dispute resolution mechanics.

Rollover equity terms for a majority recap typically include: rollover into HoldCo LLC at pro-rata sponsor cost basis, tag-along rights on sponsor exit, drag-along above a defined threshold, minority protections including reserved matters on management change and material acquisitions, and a 3 to 5 year put option at fair market value if the sponsor has not exited. The term sheet guide published on CT walks through each provision at negotiation level detail.

What are the red flags to avoid in dental practice acquisition financing?

The five red flags most likely to blow up a dental practice acquisition financing package are: owner-doctor comp not normalized before EBITDA multiple negotiation (buyer overpays by 15 to 30 percent), lease expiration inside 24 months with no assignment or extension (kills lender appetite), payer concentration above 30 percent from a single insurer (elevates transition risk), pending malpractice claim history not disclosed (triggers R&W insurance denial), and undisclosed related-party arrangements such as owner-family-owned building leased to the practice above market rent.

Lender-side red flags that emerge in credit committee: buyer with less than 24 months of clinical practice experience post-DDS, buyer with negative liquid net worth after equity injection, target with associate-doctor turnover above 40 percent trailing 24 months, target where hygiene revenue has declined for two consecutive years, and target with active insurance audit or state dental board investigation.

Sponsor-side red flags in an equity investment: founder-dentist unwilling to sign a 3 to 5 year employment and non-compete, no second-line clinical leader (single point of failure), key associate not under a modern non-solicit, and inconsistent chart-and-record hygiene that would create post-close HIPAA exposure.

What are the 2024-2026 market dynamics for dental practice acquisition financing?

The 2024-2026 dental services market has been shaped by three forces: elevated interest rates compressing debt-financeable multiples, roughly $1.2 trillion of PE dry powder maintaining bidder tension at the platform level per PitchBook Q2 2026, and DSO consolidation continuing at a slower pace than 2021 peak. US dental services M&A totaled 340 transactions in 2024 and 310 in 2025, per PitchBook, with add-ons representing 78 percent of deal count.

2024 saw the Bain Capital-led take-private of a mid-sized specialty dental group at a rumored 11x EBITDA multiple, per PR Newswire deal announcement, alongside the Ares Management continuation vehicle for Aspen Dental documented in SEC filings. 2025 brought Warburg Pincus’s investment in a Sunbelt multi-specialty group and KKR’s continued add-on program through Heartland Dental, which per company disclosures added more than 90 affiliated practices in 2025 alone.

Rate environment implications for 2026: with Prime at 7.50 percent and 10-year Treasury oscillating in a 4.0 to 4.6 percent band per US Treasury daily yield curve, debt-financeable single-office multiples have compressed roughly 0.5 to 1.0x from 2021 peak. Sponsor-backed platform multiples for high-quality assets have held up, driven by scarcity of scaled DSO platforms with clean regulatory footprints. Buyers using SBA financing benefit from a fixed cap on debt cost that private-lender competitors cannot always match on speed.

Table 4: Selected 2024-2026 dental services deal comps

How does CT Acquisitions help you find the right equity partner?

CT Acquisitions runs a competitive capital-raise process on behalf of LMM dental operators, sourcing three to seven term sheets from a curated list of family offices, growth-equity funds, and DSO platforms whose thesis matches the operator’s revenue profile, geography, and post-close role preferences. The engagement pairs a sell-side or capital-raise mandate with buy-side experience across 200-plus healthcare services transactions, and connects to the broader CT raise capital pillar, sell-side M&A, and buy-side M&A practices.

The CT process typically begins with a two-week diligence and positioning phase during which the team assembles a QoE-grade EBITDA build, a strategic rationale deck, and a targeted sponsor list of 25 to 50 investors filtered on healthcare focus, DSO history, check size fit, and prior success with similar seller archetypes. From there, a formal go-to-market runs six to twelve weeks depending on process type (broad auction, targeted auction, or negotiated bilateral).

Operator outcomes CT prioritizes: preserving founder-dentist optionality on rollover equity size, negotiating employment terms that reflect the seller’s genuine 3 to 5 year appetite, structuring earnouts and holdbacks that will not become post-close litigation, and matching the seller with a sponsor whose portfolio-company operating cadence matches the operator’s temperament. See the LMM M&A advisor guide and selling to a growth-equity investor for more on process mechanics.

How do you choose among competing dental practice acquisition financing advisors?

Choosing among competing dental practice acquisition financing advisors comes down to five filters: healthcare services deal count in the last 24 months (proxy for current market intel), sponsor and lender relationships that will actually respond to the advisor’s calls, fee structure and success-fee waterfall clarity, references from operators in the same $1M to $25M EBITDA band, and cultural fit around communication cadence during a nine to eighteen month process. Broker versus investment bank versus placement agent choices should map to deal size and complexity, per Axial LMM benchmarks.

Business brokers dominate the sub-$1M EBITDA single-office market but often lack the capital-markets range for a growth-equity minority or unitranche-backed recap. Regional M&A advisors and boutique investment banks handle the $1M to $25M EBITDA middle where CT operates and where most dental practice financings sit. Bulge-bracket investment banks generally do not engage below $25M EBITDA for economics reasons.

Placement agents specialize in raising debt or equity capital when a seller or founder wants to retain control and simply raise structured capital rather than run a sale process. For dental-specific placement work, look for relationships with the specialty lenders and BDCs listed above and prior successful placements in the same vintage window (2024-2026 is the meaningful benchmark, since 2019-2021 comps reflect an entirely different rate and dry-powder regime).

How does dental compare to other LMM healthcare services acquisitions?

Dental practice acquisition financing operates similarly to veterinary, dermatology, ophthalmology, and physical therapy acquisitions, all of which follow the MSO plus friendly PC structural playbook and attract similar sponsor sets. The main differences are payer mix (dental is heavier fee-for-service, easier lender underwriting than Medicare-heavy verticals), state regulatory intensity (dental CPD rules are variable but generally less complex than psychiatry or nursing), and sponsor concentration (dental has more mature institutional platforms than most peer verticals).

Sponsors active across the dental, vet, and dermatology consolidation waves overlap significantly. Latticework Capital, InTandem Capital Partners, MSouth Equity Partners, and Riata Capital Group all have portfolio investments across multiple healthcare services verticals. That cross-vertical operating experience shows up in add-on integration playbooks and post-close professional-services support that a first-time-in-healthcare generalist sponsor would take longer to build.

For a founder-dentist evaluating whether to sell to a dedicated DSO buyer (Heartland, Aspen, Smile Doctors) versus a multi-vertical healthcare-services sponsor, the trade-off is typically speed and certainty of close (DSO buyers) versus valuation optionality and future exit multiple upside (multi-vertical sponsors). CT’s family office versus PE buyer guide walks through the analogous decision.

What financing paths exist for a first-time dentist-buyer?

First-time dentist-buyers with 3 to 7 years of clinical experience typically finance a single-office acquisition through SBA 7(a) with a specialty lender (Live Oak, Provide, BofA Practice Solutions), a 10 percent equity injection, and a 5 to 10 percent seller note on standby. Total buyer cash-in at close ranges from $50K to $200K on a $1M to $2M enterprise-value transaction. Post-close debt service typically consumes 25 to 40 percent of free cash flow.

Alternative first-time buyer paths include associate-buy-in structures where the associate purchases 25 to 50 percent of the practice from the owner over a defined runway with retained ownership pathway to 100 percent, or partnership tracks inside a DSO such as Pacific Dental Services which offers an owner-doctor partnership model with practice-level equity at each affiliated office.

For first-time buyers considering a search-fund-style structure, established programs at Search Fund Partners, Anacapa Partners, and Pacific Lake Partners fund searcher stipends of $60K to $120K per year for 18 to 24 months, then step up as equity investors in the eventual acquisition. Search-fund-backed dental acquisitions have grown notably since 2022, per the Stanford GSB study cycle.

What is the outlook for dental practice acquisition financing in late 2026 and 2027?

The late-2026 and 2027 outlook for dental practice acquisition financing depends primarily on the Federal Reserve rate path, the pace of PE realizations that recycle capital into new platform deals, and any regulatory changes to SBA 7(a) rules or corporate-practice-of-dentistry frameworks. Consensus among healthcare M&A commentators expects continued add-on activity from established DSO platforms, moderating platform-level multiples from 2021 peaks, and stable specialty-lender appetite for sub-$10M transactions.

Regulatory watch items: SBA SOP 50 10 8 updates that took effect in 2026 tightened personal-guarantee release, seller-note standby rules, and equity-injection sourcing; further tightening in 2027 would meaningfully affect the small-office acquisition volume. State-level CPD reform proposals in several jurisdictions could either open or close specific DSO structures; the ADA state legislation tracker is the definitive source.

Capital-markets watch items: BDC dry powder tracked by the S&P Global Market Intelligence BDC database remains elevated, supporting continued unitranche availability for platform DSO leverage. Family-office allocations to healthcare services have expanded per the Institutional Investor annual family office survey. Growth-equity fund raises for healthcare-focused vehicles continue to attract LP interest despite broader PE fundraising slowdown reported by PitchBook.

Frequently asked questions

How much down payment do I need for dental practice acquisition financing in 2026?

SBA 7(a) programs typically require 10 percent buyer equity injection, of which up to 5 percent can be a full-standby seller note, per SBA SOP 50 10 8 rules effective 2026. Conventional bank loans usually want 15 to 20 percent down. Private-equity minority recaps often need zero incremental buyer equity because the sponsor writes the check against retained rollover.

Can I use SBA financing to buy a multi-location DSO?

SBA 7(a) caps at $5 million per borrower under 2026 rules, so a two or three-office roll-up can qualify if total transaction value stays inside the cap. Beyond that, buyers pair SBA with a seller note, unitranche, or split into separate SPVs. Larger multi-location DSOs almost always route through conventional cash-flow debt or private-equity backing.

What EBITDA multiple should I expect to pay for a dental practice in 2026?

Single-office general dentistry practices trade at 4x to 6x normalized EBITDA to a dentist-buyer, per GF Data 2026 healthcare services benchmarks. Multi-location groups with 3+ offices attract 6x to 8x from search funds and family offices. Emerging platforms of $3M-plus EBITDA with a repeatable de novo playbook clear 8x to 11x from growth-equity sponsors.

Who are the largest active DSO acquirers in 2026?

Named platforms currently deploying capital include Heartland Dental (backed by KKR), Aspen Dental (Ares Management), Smile Doctors (Linden Capital and Thomas H. Lee Partners), 42 North Dental (Audax), Dental Care Alliance (backed by Mubadala Capital), and Pacific Dental Services (independent). Family offices such as Fireside Investments and lower-middle-market sponsors including Riata Capital and MSouth Equity Partners also compete for platform and add-on deals.

How long does dental practice acquisition financing take to close in 2026?

SBA 7(a) with a preferred lender partner typically closes in 75 to 105 days from LOI, driven by SBA underwriting and third-party appraisals. Conventional bank debt for practice acquisitions closes in 45 to 60 days. Private-equity recaps involving quality of earnings, legal, and reg-diligence generally run 90 to 150 days from term sheet to funding.

Should I take a full sale or a minority recap from a private-equity firm?

Owners under age 55 with a growth thesis and appetite for a second bite would typically consider a minority or majority recap, retaining 20 to 40 percent equity that could be worth more at the next exit. Owners over 60 looking to fully retire in 24 to 36 months often prefer a 100 percent sale to a strategic DSO or an operator-led search fund with clean walk-away economics.

What is a healthcare-specific quality of earnings and why does it matter for dental deals?

A dental-specific quality of earnings adjusts reported EBITDA for owner-doctor comp normalization, associate-doctor compensation gaps, hygiene production allocation, insurance write-off consistency, and cash-pay procedure mix. Providers such as CBIZ, Aprio, and Withum publish dental-services QoE that lenders and PE sponsors treat as diligence-grade. Skipping it can strip 10 to 25 percent off the multiple at final papers.

Are dentist-owned associate buy-ins still viable financing paths in 2026?

Yes, associate-to-owner buy-ins remain viable and are actively bank-financed by lenders such as Live Oak Bank, Provide (Fifth Third), Bank of America Practice Solutions, and Huntington. The typical structure is a five to seven-year term loan against 100 percent of purchase price with the associate contributing sweat equity through a below-market income period pre-close rather than a large cash injection.

Related CT Acquisitions resources

• Raise capital hub
• Sell-side M&A advisory
• Buy-side M&A advisory
• Lower middle market M&A advisor
• Growth equity vs private equity
• Mezzanine debt for acquisitions guide
• Unitranche debt acquisition financing
• Selling to a growth equity investor
• Family office vs PE buyer
• What is a term sheet
• Business acquisition loan
• Leveraged buyout acquisition financing guide
• Acquisition financing overview
• Capital raising services